Pancreatic Cancer Research

Clinical trialPhase 1Completed

Epidural Analgesia Use in Pancreatic Resections

Outcome
Finished, no results posted
Phase
Phase 1
Status
Completed
Study type
Interventional
Start
7 June 2016
Ended
7 February 2020
Enrollment
23 participants
Sites
1
Primary outcomes
Total consumption of morphine or morphine-equivalent in patients undergoing pancreatic resections in the control group compared with the study group
Sponsor type
Academic / other
Results posted
No
Last update
12 March 2020

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

The rationale for this study is to investigate the benefits of epidural analgesia in pancreatic resections in a prospective, single blind, randomized control trial. This study will evaluate both short and long-term outcomes related to epidural analgesia, providing a longitudinal and comprehensive perspective to the advantages and disadvantages of this technique. The investigators hypothesize that the use of epidural analgesia reduces a patient's consumption of morphine or morphine-equivalent in the post-operative period following pancreatic resections.